KEEP BUT DO NOT DISPLAY

A new study conducted by the Institute for Alternative Futures and funded by Novo Nordisk highlighted the top 10 U.S. states that are labeled as “diabetes hot spots” and are projected to carry the brunt of the epidemic over the next 15 years. The IAF diabetes model projected that the …

Antibodies Holds Keys to Diabetes Breakthrough See this week’s Item #3.

Obese Americans have smaller paychecks than those who aren’t overweight, and this difference is especially strong among women, a new study finds. The analysis of data from the National Longitudinal Survey of Youth revealed that in 2004, overall average annual incomes were $8,666 less for obese women and $4,772 less …

Men are three times more likely than women to struggle in telling their partner they need to lose weight, research has suggested. Almost a third of men (31%) do not want to confront their partner about shedding pounds, compared with 10% of women who would not be happy to tell …

Patients want easy access to any notes their doctor has recorded about them, and they want the right to let others view their medical information, according to a pair of U.S. studies, which surveyed more than 37,000 patients and more than 170 primary care doctors. Advocates of open-access medical records …

FDA Restricts Lap-Band Claims “I lost 90 pounds with the Lap-Band” should also include that it has Serious Risks. FDA has warned eight surgical centers and a marketing firm in California about misleading advertising of the Lap-Band.

Linagliptin, a DPP-4 inhibitor currently under clinical development for type 2 diabetes, produced “meaningful” reductions in blood sugar, according to results of a late-stage clinical study. The results of a 24-week, open-label arm of a phase-3 study of the investigational drug linagliptin combined with the generic drug metformin, were announced …

In the latest results, dapagliflozin improved control when glimepiride was added. Through 48 weeks, dapagliflozin plus glimepiride reduced HbA1c levels by 0.37% to 0.70% compared with placebo plus glimepiride. There were also sustained reductions in fasting plasma glucose and post-prandial glucose and small reductions in total body weight (1.3 to …

Two take-outs a week are enough to increase the risk of diabetes and heart disease, research shows. Young adults were more likely to have hidden health problems if they treated themselves to fast food on a twice-weekly basis, the study found. Additionally, women appear to be more susceptible to the …

FDA Approves Sanofi’s iBGStar iPhone Glucose Monitor See Product of the Week below.